Researchers used a unique base-editing strategy to engineer chimeric-antigen receptor (CAR) T cells that engraft in the host and remain invisible to remaining antibody drugs. Of the 11 patients with T ...
1The Second Clinical Medical School, Lanzhou University, Lanzhou, China. 2Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China. 3Gansu Tumor Immunology Basic Disciplines ...
In a large retrospective study, those taking a glucagon-like peptide 1 (GLP-1) receptor agonist drug were 36% less likely to develop colorectal cancer than those taking aspirin. Although the benefit ...
1Division of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida. 2Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami ...
2Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, Illinois. 3Robert H. Lurie Comprehensive Cancer Center ...
1Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California. 2Cancer Institute, Stanford University School of Medicine, Stanford, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results